Sutro Biopharma Balance Sheet
Sutro Biopharma's total assets for Q4 2025 were $173.83M, a decrease of -17.09% from the previous quarter. STRO total liabilities were $306.28M for the fiscal quarter, a 3.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.